STOCK TITAN
  1. Home
  2. News
  3. BSGM

Biosig Technologies Inc - BSGM STOCK NEWS

Welcome to our dedicated news page for Biosig Technologies (Ticker: BSGM), a resource for investors and traders seeking the latest updates and insights on Biosig Technologies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Biosig Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Biosig Technologies's position in the market.

News
BioSig Engages Consulting Firm for Business Model Strategies
Rhea-AI Summary
BioSig Technologies, Inc. appoints Bridge Associates International Pharmaceutical Consulting (BAIPC) to advise on business model strategies, aiming to transform the company's future course by implementing solutions to address operational and financial deficits.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.39%
Tags
none
-
News
BioSig Announces Reduction of its Workforce
Rhea-AI Summary
BioSig Technologies, Inc. (BSGM) announced a significant reduction in employees and business operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.78%
Tags
none
-
News
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
Rhea-AI Summary
BioSig Technologies, Inc. (NASDAQ: BSGM) announced the successful adoption of its Near Field Tracking (NFT) algorithm, which has reduced ablation time by approximately 66%. Physicians have completed over 100 cases with the NFT algorithm, providing tissue-specific feedback and color-coded characterization in real time. The software has been leveraged at major medical centers and health systems, receiving positive feedback from leading cardiac electrophysiologists. This innovative feature is expected to significantly improve procedural efficiency and accuracy in cardiac ablation procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.05%
Tags
none
News
BioSig Announces Reverse Stock Split
Rhea-AI Summary
BioSig Technologies, Inc. (NASDAQ: BSGM) will undergo a reverse stock split at a ratio of 1 post-split share for every 10 pre-split shares, effective February 2, 2024. The reverse stock split will reduce the outstanding shares from 93,344,435 to approximately 9,334,636. The new CUSIP number for the common stock following the reverse stock split will be 09073N3008.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.64%
Tags
stock split
-
News
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
Rhea-AI Summary
BioSig Technologies, Inc. (NASDAQ: BSGM) announced a workforce reduction to reduce annual cash burn by 50%. The company is shifting its business model to partner with organizations for sales distribution and clinical support of its PURE EP™ Platform. The platform's NFT algorithm has shown a 66% reduction in ablation time, and the company is looking to expand its applications and quantify the efficacy and safety benefits of NFT.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.96%
Tags
none
-
News
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
Rhea-AI Summary
BioSig Technologies, Inc. (Nasdaq: BSGM) issued its 2023 letter to shareholders, highlighting recent achievements and insights.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.02%
Tags
none
News
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Rhea-AI Summary
BioSig Technologies, Inc. (NASDAQ: BSGM) announced the closing of a registered direct offering, issuing 6,996,922 shares of common stock, Series A and Series B warrants. The offering was priced at $0.3573 per share, with gross proceeds of approximately $2.5 million. H.C. Wainwright & Co. acted as the exclusive placement agent. The net proceeds will be used for working capital and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.91%
Tags
offering
-
News
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Rhea-AI Summary
BioSig Technologies, Inc. (NASDAQ: BSGM) announces a registered direct offering of 6,996,922 shares of its common stock, Series A and Series B warrants at $0.3573 per share, with H.C. Wainwright & Co. as the exclusive placement agent.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.64%
Tags
offering
-
News
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
Rhea-AI Summary
BioSig Technologies, Inc. (NASDAQ: BSGM) appoints Frederick Hrkac, a 32-year medical device industry veteran, as Executive Vice President. His extensive experience includes leading Johnson & Johnson's cardiology/electrophysiology business to a $500M revenue and facilitating a $1B sale of a medical device company in 2018.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.87%
Tags
management
News
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
Rhea-AI Summary
BioSig Technologies, Inc. announced that Mayo Clinic-Phoenix has upgraded to the PURE EP™ Platform's subscription model to access the latest advancements in cardiac arrhythmia identification. The new software features include Automatic Tachycardia Characterization (ATC) and Near-Field Tracking (NFT) to assist electrophysiologists in ablation procedures. Mayo Clinic-Phoenix is ranked as the number one hospital in Arizona and is now part of the PURE EP™ subscriber community, along with Cleveland Clinic.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
none
Stock BSGM logo
Biosig Technologies Inc

Nasdaq:BSGM

BSGM Rankings

#5245 Ranked by Market Cap
#2437 Ranked by Stock Gains
N/A Ranked by Dividends

BSGM Stock Data

14.10M
6.29M
22.56%
11.41%
7.44%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Westport

About BSGM

biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.